CTOs on the Move

Pointe Scientific

www.pointescientific.com

 
Pointe Scientific Inc. is a Canton, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

TransEngen

TransEngen is a Norwalk, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Innovations

Cardinal Innovations Healthcare is the leading provider of managed care services in the U.S. Cardinal Innovations, the nations largest specialty health plan and the pioneer of a unique managed healthcare model, incorporates a community-based model of care management, a network of highly-skilled providers and local support partners to improve the health and wellness of plan members. Cardinal Innovations serves members through Medicaid, state and county-funded plans and supports a variety of initiatives for Veterans and their families through centralized call center services and other collaborative initiatives.

NinePoint Medical

NinePoint Medical is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oklahoma Rsdntl Assisted Livng

Oklahoma Rsdntl Assisted Livng is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.